• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

鉴定参与细胞转化的 PP2A 复合物和途径。

Identification of PP2A complexes and pathways involved in cell transformation.

机构信息

Department of Medical Oncology, Dana-Farber Cancer Institute, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA.

出版信息

Cancer Res. 2010 Dec 15;70(24):10474-84. doi: 10.1158/0008-5472.CAN-10-2855.

DOI:10.1158/0008-5472.CAN-10-2855
PMID:21159657
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3056544/
Abstract

The simian virus 40 small t (SV40ST) oncoprotein interacts with protein phosphatase 2A (PP2A), an abundantly expressed family of serine-threonine phosphatases. This interaction is essential for the transformation of human cells by SV40, and several PP2A subunits have been implicated as tumor suppressor genes. However, the pathways controlled by specific PP2A complexes involved in cell transformation remain incompletely understood. Using a comprehensive loss-of-function approach, we identified 4 PP2A regulatory subunits [B56α, B56γ, PR72/PR130, and PTPA (protein phosphatase 2A activator)], which when suppressed replaced the expression of SV40ST in human cell transformation. We found that manipulation of complexes containing PP2A B56α, B56γ, and PR72/PR130 activates the pathways regulated by c-Myc, Wnt, and PI3K (phosphoinositide 3-kinase)/Akt in a manner that depends on their specific phosphatase activity. In contrast, suppression of PTPA disrupts the assembly of PP2A heterotrimeric complexes, which leads to the activation of these same oncogenic pathways. These observations delineate the PP2A family members and pathways perturbed by SV40ST during human cell transformation.

摘要

猿猴病毒 40 小 t(SV40ST)癌蛋白与蛋白磷酸酶 2A(PP2A)相互作用,PP2A 是一种丰富表达的丝氨酸-苏氨酸磷酸酶家族。这种相互作用对于 SV40 转化人类细胞是必不可少的,并且已经有几个 PP2A 亚基被认为是肿瘤抑制基因。然而,参与细胞转化的特定 PP2A 复合物所控制的途径仍不完全清楚。我们使用全面的功能丧失方法,鉴定出 4 种 PP2A 调节亚基[B56α、B56γ、PR72/PR130 和 PTPA(蛋白磷酸酶 2A 激活剂)],当这些亚基被抑制时,它们可以替代 SV40ST 在人类细胞转化中的表达。我们发现,操纵含有 PP2A B56α、B56γ 和 PR72/PR130 的复合物会以依赖于其特定磷酸酶活性的方式激活 c-Myc、Wnt 和 PI3K(磷酸肌醇 3-激酶)/Akt 调节的途径。相比之下,抑制 PTPA 会破坏 PP2A 异三聚体复合物的组装,从而导致这些相同的致癌途径被激活。这些观察结果描绘了 SV40ST 在人类细胞转化过程中扰动的 PP2A 家族成员和途径。

相似文献

1
Identification of PP2A complexes and pathways involved in cell transformation.鉴定参与细胞转化的 PP2A 复合物和途径。
Cancer Res. 2010 Dec 15;70(24):10474-84. doi: 10.1158/0008-5472.CAN-10-2855.
2
The PP2A subunit PR130 is a key regulator of cell development and oncogenic transformation.蛋白磷酸酶 2A 的亚基 PR130 是细胞发育和致癌转化的关键调节因子。
Biochim Biophys Acta Rev Cancer. 2020 Dec;1874(2):188453. doi: 10.1016/j.bbcan.2020.188453. Epub 2020 Oct 15.
3
Protein phosphatase 2A regulatory subunit B56alpha associates with c-myc and negatively regulates c-myc accumulation.蛋白磷酸酶2A调节亚基B56α与c-myc结合并负向调节c-myc的积累。
Mol Cell Biol. 2006 Apr;26(7):2832-44. doi: 10.1128/MCB.26.7.2832-2844.2006.
4
Identification of specific PP2A complexes involved in human cell transformation.鉴定参与人类细胞转化的特定PP2A复合物。
Cancer Cell. 2004 Feb;5(2):127-36. doi: 10.1016/s1535-6108(04)00026-1.
5
Liprin alpha1 interacts with PP2A B56gamma.脂磷素α1与蛋白磷酸酶2A B56γ相互作用。
Cell Cycle. 2008 Feb 15;7(4):525-32. doi: 10.4161/cc.7.4.5390. Epub 2007 Nov 30.
6
The role of PP2A A subunits in tumor suppression.蛋白磷酸酶2A A亚基在肿瘤抑制中的作用。
Cell Adh Migr. 2007 Jul-Sep;1(3):140-1. doi: 10.4161/cam.1.3.4986. Epub 2007 Jul 5.
7
Circumventing cellular control of PP2A by methylation promotes transformation in an Akt-dependent manner.通过甲基化绕过细胞对 PP2A 的控制,以 Akt 依赖的方式促进转化。
Neoplasia. 2012 Jul;14(7):585-99. doi: 10.1593/neo.12768.
8
Activation of PP2A and Inhibition of mTOR Synergistically Reduce MYC Signaling and Decrease Tumor Growth in Pancreatic Ductal Adenocarcinoma.PP2A 的激活和 mTOR 的抑制协同作用降低胰腺导管腺癌中的 MYC 信号传导并减少肿瘤生长。
Cancer Res. 2019 Jan 1;79(1):209-219. doi: 10.1158/0008-5472.CAN-18-0717. Epub 2018 Nov 2.
9
PP2A Inactivation Mediated by Haploinsufficiency Promotes Cancer Development.PP2A 失活介导的杂合不足促进癌症发展。
Cancer Res. 2017 Dec 15;77(24):6825-6837. doi: 10.1158/0008-5472.CAN-16-2911. Epub 2017 Oct 18.
10
Involvement of PP2A in viral and cellular transformation.蛋白磷酸酶2A在病毒及细胞转化中的作用。
Oncogene. 2005 Nov 21;24(52):7746-55. doi: 10.1038/sj.onc.1209038.

引用本文的文献

1
AKR1B10 dictates c-Myc stability to suppress colorectal cancer metastasis via PP2A nitration.醛酮还原酶1B10通过蛋白磷酸酶2A硝化作用决定c-Myc稳定性以抑制结直肠癌转移。
Sci Adv. 2025 Aug 22;11(34):eadv6937. doi: 10.1126/sciadv.adv6937.
2
Regulatory mechanisms of PP2A complex assembly driven by physicochemical differences in A-subunit isoforms.由A亚基亚型的物理化学差异驱动的PP2A复合物组装的调控机制。
Structure. 2025 Jul 15. doi: 10.1016/j.str.2025.06.013.
3
PR55α subunit of protein phosphatase 2A supports KRAS-driven tumorigenesis that requires YAP activation.蛋白磷酸酶2A的PR55α亚基支持KRAS驱动的肿瘤发生,这需要YAP激活。
Oncogene. 2025 Jun 26. doi: 10.1038/s41388-025-03477-y.
4
Hypoxia exposure impairs male fertility via inhibiting Septin2-mediated spermatogonial proliferation.低氧暴露通过抑制Septin2介导的精原细胞增殖损害雄性生育能力。
Hum Reprod Open. 2025 May 14;2025(3):hoaf027. doi: 10.1093/hropen/hoaf027. eCollection 2025.
5
Germline mutations in PPP2R1B in patients with a personal and family history of cancer.有个人和家族癌症病史患者中PPP2R1B的种系突变。
JCI Insight. 2025 Apr 3;10(9). doi: 10.1172/jci.insight.186288. eCollection 2025 May 8.
6
Evaluation of Prenatal Transportation Stress on DNA Methylation (DNAm) and Gene Expression in the Hypothalamic-Pituitary-Adrenal (HPA) Axis Tissues of Mature Brahman Cows.产前运输应激对成年婆罗门牛下丘脑-垂体-肾上腺(HPA)轴组织中DNA甲基化(DNAm)和基因表达的影响评估
Genes (Basel). 2025 Feb 4;16(2):191. doi: 10.3390/genes16020191.
7
Pathogenic de novo variants in PPP2R5C cause a neurodevelopmental disorder within the Houge-Janssens syndrome spectrum.PPP2R5C基因的致病性新生变异导致了豪格-扬森斯综合征谱系内的一种神经发育障碍。
Am J Hum Genet. 2025 Mar 6;112(3):554-571. doi: 10.1016/j.ajhg.2025.01.021. Epub 2025 Feb 19.
8
Small-molecule modulators of B56-PP2A restore 4E-BP function to suppress eIF4E-dependent translation in cancer cells.B56-PP2A的小分子调节剂可恢复4E-BP功能,以抑制癌细胞中eIF4E依赖性翻译。
J Clin Invest. 2025 Jan 27;135(4):e176093. doi: 10.1172/JCI176093.
9
Direct observation of small molecule activator binding to single PR65 protein.小分子激活剂与单个PR65蛋白结合的直接观察
NPJ Biosens. 2025;2(1):2. doi: 10.1038/s44328-024-00018-7. Epub 2025 Jan 16.
10
Spatially Resolved Molecular Characterization of Noninvasive Follicular Thyroid Neoplasms with Papillary-like Nuclear Features (NIFTPs) Identifies a Distinct Proteomic Signature Associated with RAS-Mutant Lesions.具有乳头状核特征的非侵袭性滤泡性甲状腺肿瘤(NIFTPs)的空间分辨分子特征鉴定出与RAS突变病变相关的独特蛋白质组学特征。
Int J Mol Sci. 2024 Dec 6;25(23):13115. doi: 10.3390/ijms252313115.

本文引用的文献

1
Protein phosphatase 2A PR130/B''alpha1 subunit binds to the SH2 domain-containing inositol polyphosphate 5-phosphatase 2 and prevents epidermal growth factor (EGF)-induced EGF receptor degradation sustaining EGF-mediated signaling.蛋白磷酸酶 2A PR130/B''alpha1 亚基与含有 SH2 结构域的肌醇多磷酸 5-磷酸酶 2 结合,防止表皮生长因子 (EGF)诱导的 EGF 受体降解,从而维持 EGF 介导的信号转导。
FASEB J. 2010 Feb;24(2):538-47. doi: 10.1096/fj.09-140228. Epub 2009 Oct 13.
2
PME-1 protects extracellular signal-regulated kinase pathway activity from protein phosphatase 2A-mediated inactivation in human malignant glioma.PME-1可保护细胞外信号调节激酶通路活性,使其免受蛋白磷酸酶2A介导的人恶性胶质瘤失活作用。
Cancer Res. 2009 Apr 1;69(7):2870-7. doi: 10.1158/0008-5472.CAN-08-2760. Epub 2009 Mar 17.
3
CDK8 is a colorectal cancer oncogene that regulates beta-catenin activity.细胞周期蛋白依赖性激酶8(CDK8)是一种调节β-连环蛋白活性的结直肠癌致癌基因。
Nature. 2008 Sep 25;455(7212):547-51. doi: 10.1038/nature07179. Epub 2008 Sep 14.
4
Protein phosphatase 2A regulatory subunits and cancer.蛋白磷酸酶2A调节亚基与癌症
Biochim Biophys Acta. 2009 Jan;1795(1):1-15. doi: 10.1016/j.bbcan.2008.05.005. Epub 2008 Jun 3.
5
A tumor suppressor role for PP2A-B56alpha through negative regulation of c-Myc and other key oncoproteins.PP2A-B56α 通过对 c-Myc 和其他关键癌蛋白的负调控发挥肿瘤抑制作用。
Cancer Metastasis Rev. 2008 Jun;27(2):147-58. doi: 10.1007/s10555-008-9128-9.
6
Structural basis of PP2A inhibition by small t antigen.小t抗原对PP2A抑制作用的结构基础
PLoS Biol. 2007 Aug;5(8):e202. doi: 10.1371/journal.pbio.0050202.
7
Integrative genomic approaches identify IKBKE as a breast cancer oncogene.整合基因组学方法确定IKBKE为一种乳腺癌致癌基因。
Cell. 2007 Jun 15;129(6):1065-79. doi: 10.1016/j.cell.2007.03.052.
8
Generation of active protein phosphatase 2A is coupled to holoenzyme assembly.活性蛋白磷酸酶2A的产生与全酶组装相关联。
PLoS Biol. 2007 Jun;5(6):e155. doi: 10.1371/journal.pbio.0050155.
9
The tumor suppressor PP2A Abeta regulates the RalA GTPase.肿瘤抑制因子PP2A Abeta调节RalA GTP酶。
Cell. 2007 Jun 1;129(5):969-82. doi: 10.1016/j.cell.2007.03.047.
10
Structural and biochemical insights into the regulation of protein phosphatase 2A by small t antigen of SV40.对SV40小t抗原调控蛋白磷酸酶2A的结构和生化见解。
Nat Struct Mol Biol. 2007 Jun;14(6):527-34. doi: 10.1038/nsmb1254. Epub 2007 May 27.